TissueGene-C promotes an anti-inflammatory micro-environment in a rat monoiodoacetate model of osteoarthritis via polarization of M2 macrophages leading to pain relief and structural improvement.

Inflammopharmacology
Hyeonyoul LeeHeonsik Choi

Abstract

Osteoarthritis (OA) is the most common form of arthritis, characterized by cartilage destruction, pain and inflammation in the joints. Existing medications can provide relief from the symptoms, but their effects on the progression of the disease are limited. TissueGene-C (TG-C) is a novel cell and gene therapy for the treatment of OA, comprising a mixture of human allogeneic chondrocytes and irradiated cells engineered to overexpress transforming growth factor-β1 (TGF-β1). This study aims to investigate the efficacy and mechanism of action of TG-C in a rat model of OA. Using the monosodium-iodoacetate (MIA) model of OA, we examined whether TG-C could improve OA symptoms and cartilage structure in rats. Our results showed that TG-C provided pain relief and cartilage structural improvement in the MIA OA model over 56 days. In parallel with these long-term effects, cytokine profiles obtained on day 4 revealed increased expression of interleukin-10 (IL-10), an anti-inflammatory cytokine, in the synovial lavage fluid. Moreover, the increased levels of TGF-β1 and IL-10 caused by TG-C induced the expression of arginase 1, a marker of M2 macrophages, and decreased the expression of CD86, a marker of M1 macrophages. These results sugges...Continue Reading

References

Jun 1, 1991·Seminars in Arthritis and Rheumatism·J P PelletierJ Martel-Pelletier
Jan 1, 1980·Annual Review of Pharmacology and Toxicology·W J Dixon
Aug 2, 2005·Nature Reviews. Immunology·Vincenzo Bronte, Paola Zanovello
Nov 22, 2005·Cytokine & Growth Factor Reviews·Christoph BeckerMarkus F Neurath
Feb 8, 2006·Current Opinion in Rheumatology·Leena SharmaSakeba Issa
Feb 24, 2006·The New England Journal of Medicine·David T Felson
Mar 30, 2007·Osteoarthritis and Cartilage·E N Blaney DavidsonW B van den Berg
Nov 26, 2008·Nature Reviews. Immunology·David M Mosser, Justin P Edwards
Sep 22, 2009·British Journal of Pharmacology·Markus Munder
Mar 20, 2010·Journal of the American Society of Nephrology : JASN·Qi CaoDavid C H Harris
Jul 24, 2010·British Journal of Pharmacology·J C McGrathC L Wainwright
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Oct 26, 2011·Current Stem Cell Research & Therapy·Jonathan R PereraWasim S Khan
Mar 7, 2012·Arthritis and Rheumatism·Richard F LoeserMary B Goldring
Oct 9, 2012·Osteoarthritis and Cartilage·D T Felson
Oct 19, 2012·International Journal of Experimental Pathology·Rachel A Oldershaw
Dec 1, 2012·Osteoarthritis and Cartilage·F Berenbaum
Apr 23, 2013·The American Journal of Pathology·Lizhi He, Alexander G Marneros
May 4, 2013·Therapeutic Advances in Musculoskeletal Disease·Jeremy Sokolove, Christin M Lepus
Feb 1, 2012·Advances in Wound Care·Christopher J Ferrante, Samuel Joseph Leibovich
Apr 5, 2014·Immunology Letters·Zhilong JiangGuang-Xian Zhang
Jan 30, 2015·Journal of Cellular Physiology·Meiyan DaiDao Wen Wang
Jun 11, 2015·BMC Musculoskeletal Disorders·Hyun Joo YoonKwan Hee Lee
Oct 19, 2016·Current Opinion in Rheumatology·Carla R Scanzello
Apr 7, 2017·Nature Reviews. Rheumatology·Ali MobasheriUrsula Fearon
Jul 15, 2017·Osteoarthritis and Cartilage·M H LiQ Zhu

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage
PCR
flow cytometry

Software Mentioned

Image
xPONENT
Pro ® Plus
ARRIVE
Sigma plot

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.